150 related articles for article (PubMed ID: 27410178)
21. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia.
Schipani E; Kruse K; Jüppner H
Science; 1995 Apr; 268(5207):98-100. PubMed ID: 7701349
[TBL] [Abstract][Full Text] [Related]
22. PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development.
Schipani E; Provot S
Birth Defects Res C Embryo Today; 2003 Nov; 69(4):352-62. PubMed ID: 14745975
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism.
Parfitt AM; Schipani E; Rao DS; Kupin W; Han ZH; Jüppner H
J Clin Endocrinol Metab; 1996 Oct; 81(10):3584-8. PubMed ID: 8855805
[TBL] [Abstract][Full Text] [Related]
25. [Cytokines in bone diseases. Genetic defects of PTH/PTHrP receptor in chondrodysplasia].
Ogata N
Clin Calcium; 2010 Oct; 20(10):1481-8. PubMed ID: 20890029
[TBL] [Abstract][Full Text] [Related]
26. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing.
Marsell R; Jonsson KB; Cho TJ; Einhorn TA; Ohlsson C; Schipani E
Acta Orthop; 2007 Feb; 78(1):39-45. PubMed ID: 17453391
[TBL] [Abstract][Full Text] [Related]
27. Receptors for parathyroid hormone and parathyroid hormone-related peptide: from molecular cloning to definition of diseases.
Jüppner H; Schipani E
Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):300-6. PubMed ID: 8823526
[TBL] [Abstract][Full Text] [Related]
28. Identification of six novel PTH1R mutations in families with a history of primary failure of tooth eruption.
Risom L; Christoffersen L; Daugaard-Jensen J; Hove HD; Andersen HS; Andresen BS; Kreiborg S; Duno M
PLoS One; 2013; 8(9):e74601. PubMed ID: 24058597
[TBL] [Abstract][Full Text] [Related]
29. Novel mutations in the parathyroid hormone (PTH)/PTH-related peptide receptor type 1 causing Blomstrand osteochondrodysplasia types I and II.
Hoogendam J; Farih-Sips H; Wÿnaendts LC; Löwik CW; Wit JM; Karperien M
J Clin Endocrinol Metab; 2007 Mar; 92(3):1088-95. PubMed ID: 17164305
[TBL] [Abstract][Full Text] [Related]
30. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
Zhang P; Jobert AS; Couvineau A; Silve C
J Clin Endocrinol Metab; 1998 Sep; 83(9):3365-8. PubMed ID: 9745456
[TBL] [Abstract][Full Text] [Related]
31. [The PTH/PTHrP receptor: biological implications].
Ureña P
Nefrologia; 2003; 23 Suppl 2():12-7. PubMed ID: 12778847
[TBL] [Abstract][Full Text] [Related]
32. Nonparathyroid Hypercalcemia.
Goltzman D
Front Horm Res; 2019; 51():77-90. PubMed ID: 30641526
[TBL] [Abstract][Full Text] [Related]
33. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
[TBL] [Abstract][Full Text] [Related]
34. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
35. Calcium metabolism in the Jansen type of metaphyseal dysplasia.
Kruse K; Schütz C
Eur J Pediatr; 1993 Nov; 152(11):912-5. PubMed ID: 8276022
[TBL] [Abstract][Full Text] [Related]
36. Partial rescue of PTH/PTHrP receptor knockout mice by targeted expression of the Jansen transgene.
Soegiarto DW; Kiachopoulos S; Schipani E; Jüppner H; Erben RG; Lanske B
Endocrinology; 2001 Dec; 142(12):5303-10. PubMed ID: 11713230
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone-independent hypercalcemia in an infant with renal dysplasia: possible role of PTHrP.
Grob F; Zambrano P; Ibarra X; Reyes ML
J Pediatr Endocrinol Metab; 2013; 26(3-4):365-7. PubMed ID: 23327815
[TBL] [Abstract][Full Text] [Related]
38. A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia.
Karperien M; van der Harten HJ; van Schooten R; Farih-Sips H; den Hollander NS; Kneppers SL; Nijweide P; Papapoulos SE; Löwik CW
J Clin Endocrinol Metab; 1999 Oct; 84(10):3713-20. PubMed ID: 10523019
[TBL] [Abstract][Full Text] [Related]
39. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
Okazaki R
Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031
[TBL] [Abstract][Full Text] [Related]
40. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
Firek AF; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
